Guardant Health, Inc. Contracts & Agreements

Open Market Sale AgreementSM by and between the Company and Jefferies LLC, dated August 23, 2024 (Filed With SEC on August 23, 2024)

Amended and Restated Executive Severance Plan (Filed With SEC on August 7, 2024)

Form of Stock Option Agreement under the 2018 Incentive Award Plan (Filed With SEC on August 7, 2024)

Form of Restricted Stock Unit Award Agreement under the 2018 Incentive Award Plan (Filed With SEC on August 7, 2024)

Form of Performance-Based Restricted Stock Unit Award Agreement under the 2018 Incentive Award Plan (Filed With SEC on August 7, 2024)

Form of Stock Option Grant Notice and Restricted Stock Unit Grant Notice under the 2023 Employment Inducement Incentive Award Plan (Filed With SEC on August 7, 2024)

Form of Letter Agreement (Filed With SEC on March 22, 2024)

Common Stock Purchase Agreement, dated December 20, 2023, between Guardant Health, Inc. and Baillie Gifford Overseas Limited, acting as agent and representative for and on behalf... (Filed With SEC on December 21, 2023)

2023 Employment Inducement Incentive Award Plan, as approved on August 2, 2023 (Filed With SEC on November 6, 2023)

Form of Stock Option Grant Notice and Restricted Stock Unit Grant Notice under the 2023 Employment Inducement Incentive Award Plan (Filed With SEC on November 6, 2023)

Executive Severance Plan (Filed With SEC on August 3, 2023)

Underwriting Agreement, dated as of May 22, 2023, among Guardant Health, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC and SVB Securities... (Filed With SEC on May 25, 2023)

Forms of Performance-Based Restricted Stock Unit Award Agreement under the 2018 Incentive Award Plan (Filed With SEC on February 25, 2021)

Amendment #5 to Supply Agreement, dated January 1, 2021, by and between the Registrant and Illumina, Inc (Filed With SEC on February 25, 2021)

Offer Letter, dated December 4, 2020, by and between Guardant Health, Inc. and Michael Bell (Filed With SEC on December 11, 2020)

Employment Letter, dated December 7, 2020, by and between Guardant Health, Inc. and Derek Bertocci (Filed With SEC on December 11, 2020)

Indenture, dated as of November 19, 2020, between Guardant Health, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on November 20, 2020)

Form of Capped Call Confirmation (Filed With SEC on November 20, 2020)

Sublease Agreement, dated July 31, 2020, by and between Guardant Health, Inc. and 3000 Hanover, LLC (Filed With SEC on November 5, 2020)

Underwriting Agreement, dated October 6, 2020, by and among Guardant Health, Inc., SVF Bluebird (Cayman) Limited and J.P. Morgan Securities LLC (Filed With SEC on October 13, 2020)

Non-Employee Director Compensation Program, effective as of June 12, 2020 (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated June 1, 2020, by and among Guardant Health, Inc., SVF Bluebird (Cayman) Limited and J.P. Morgan Securities LLC (Filed With SEC on June 4, 2020)

Form of Performance-Based Restricted Stock Unit Agreement (Filed With SEC on May 27, 2020)

Form of Waiver Letter Agreement (Filed With SEC on May 27, 2020)

Description of Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 2, 2020)

Advisor Agreement, dated February 28, 2020, by and between Guardant Health, Inc. and Richard Lanman (Filed With SEC on March 2, 2020)

Form of Underwriting Agreement (Filed With SEC on May 20, 2019)

Non-Employee Director Compensation Program (Filed With SEC on May 10, 2019)

Offer Letter, dated May 13, 2018, by and between Guardant Health, Inc. and Leena Das-Young (Filed With SEC on May 10, 2019)

Offer Letter, dated July 29, 2014, by and between Guardant Health, Inc. and Richard Lanman (Filed With SEC on May 10, 2019)

First Amendment to 2018 Employee Stock Purchase Plan (Filed With SEC on March 19, 2019)

Form of letter agreement relating to certain time-based equity awards held by Helmy Eltoukhy and AmirAli Talasaz (Filed With SEC on March 19, 2019)

First Amendment to Executive Severance Plan (Filed With SEC on March 19, 2019)

Amended and Restated Offer Letter Agreement, dated September 16, 2018, by and between Guardant Health, Inc. and Ian Clark (Filed With SEC on November 19, 2018)

Amended and Restated Offer Letter Agreement, dated September 16, 2018, by and between Guardant Health, Inc. and Stanley Meresman (Filed With SEC on November 19, 2018)

Form of Underwriting Agreement (Filed With SEC on September 21, 2018)

Joint Venture Agreement, dated May 9, 2017, by and between the Registrant and SoftBank Vision Fund (AIV M1) L.P., as assignee from SoftBank Group Capital Limited (Filed With SEC on September 21, 2018)

Patent License Agreement, dated January 1, 2017, by and between the Registrant and KeyGene N.V (Filed With SEC on September 21, 2018)

Form of the Registrants 2018 Incentive Award Plan (Filed With SEC on September 21, 2018)

Form of the Registrants 2018 Employee Stock Purchase Plan (Filed With SEC on September 21, 2018)

Form of Executive Severance Plan of the Registrant (Filed With SEC on September 21, 2018)

Form of Non-Employee Director Compensation Program (Filed With SEC on September 21, 2018)

Form of Stock Option Agreement under the Registrants 2018 Incentive Award Plan (Filed With SEC on September 21, 2018)

Form of Restricted Stock Award Agreement under the Registrants 2018 Incentive Award Plan (Filed With SEC on September 21, 2018)

Form of Restricted Stock Unit Award Agreement under the Registrants 2018 Incentive Award Plan (Filed With SEC on September 21, 2018)

Form of Indemnification Agreement between the Registrant and its directors and officers (Filed With SEC on September 18, 2018)

Form of Amended and Restated Offer Letter Agreement, by and between the Registrant and Ian Clark (Filed With SEC on September 18, 2018)

Form of Amended and Restated Offer Letter Agreement, by and between the Registrant and Stanley Meresman (Filed With SEC on September 18, 2018)

Form of Common Stock Purchase Warrant of the Registrant (Filed With SEC on September 6, 2018)

Warrant to Purchase Series A Preferred Stock (Filed With SEC on September 6, 2018)

Second Warrant to Purchase Series B Preferred Stock (Filed With SEC on September 6, 2018)

Amended and Restated Investors Rights Agreement, dated May 9, 2017, by and among the Registrant and the investors listed therein (Filed With SEC on September 6, 2018)

Lease, dated November 1, 2014, by and between the Registrant and Metropolitan Life Insurance Company (Filed With SEC on September 6, 2018)

Amended and Restated 2012 Stock Plan of the Registrant (Filed With SEC on September 6, 2018)

Form of Notice of Stock Option Grant and Stock Option Agreement under the Registrants Amended and Restated 2012 Stock Plan (Filed With SEC on September 6, 2018)

Joint Venture Agreement, dated May 9, 2017, by and between the Registrant and SoftBank Group Capital Limited (Filed With SEC on September 6, 2018)

Patent License Agreement, dated January 1, 2017, by and between the Registrant and KeyGene N.V (Filed With SEC on September 6, 2018)

Supply Agreement, dated September 15, 2014, by and between the Registrant and Illumina, Inc (Filed With SEC on September 6, 2018)

First Amendment to Lease, dated October 17, 2017, by and between the Registrant and Metropolitan Life Insurance Company (Filed With SEC on September 6, 2018)

Amendment to Supply Agreement, dated August 11, 2015, by and between the Registrant and Illumina, Inc (Filed With SEC on September 6, 2018)

Amendment #2 to Supply Agreement, dated December 24, 2016, by and between the Registrant and Illumina, Inc (Filed With SEC on September 6, 2018)

Amendment #3 to Supply Agreement, dated August 14, 2017, by and between the Registrant and Illumina, Inc (Filed With SEC on September 6, 2018)

Amendment #4 to Supply Agreement, dated June 26, 2018, by and between the Registrant and Illumina, Inc (Filed With SEC on September 6, 2018)

Category

Industry

Companies

Contracts

Guardant Health, Inc. Contracts & Agreements